Evaluating the costs and benefits of pneumococcal vaccination in adults.
作者： Barbara Rita Porchia , Paolo Bonanni , Angela Bechini , Gugliemo Bonaccorsi , Sara Boccalini
DOI: 10.1080/14760584.2017.1242419
关键词: Pneumococcal vaccine 、 Public health 、 Cost effectiveness 、 Immunology 、 Scopus 、 Medicine 、 Pneumococcal disease 、 Economic evaluation 、 Intensive care medicine 、 Cost–benefit analysis 、 Pneumococcal vaccination
摘要: ABSTRACTIntroduction: Pneumococcal infection is a public health concern that disproportionately affects the young, elderly, and immunocompromised. There an open debate on implementation of polysaccharide and/or conjugate vaccines for pneumococcal diseases in adults elderly many countries. The aim this paper to systematically review economic profile terms costs benefits.Areas covered: search studies vaccination was carried out Pubmed, Embase, Scopus, HTA NHS EED databases through manual journals dealing with evaluations. We included original articles reviews evaluation 23-valent (PPV23) vaccine 13-valent (PCV13) use adults, at-risk groups provide systematic economical evaluation.Expert commentary: strongly recommended all ad...
sci-hub.se 参考文章(46)
Patrícia Coelho de Soárez, Ana Marli Christovam Sartori, Angela Carvalho Freitas, Álvaro Mitsunori Nishikawa, Hillegonda Maria Dutilh Novaes, Cost-Effectiveness Analysis of Universal Vaccination of Adults Aged 60 Years with 23-Valent Pneumococcal Polysaccharide Vaccine versus Current Practice in Brazil PLOS ONE. ,vol. 10, pp. e0130217- ,(2015) , 10.1371/JOURNAL.PONE.0130217
Janne A. Martikainen, Erkki J. Soini, Juha Laine, Heidi Åhman, Ville Postila, Peter Klemets, Economic impact of 13-valent pneumococcal conjugate vaccine in Finnish adults ≥50 years with underlying chronic medical conditions. Journal of Evaluation in Clinical Practice. ,vol. 20, pp. 333- 341 ,(2014) , 10.1111/JEP.12131
S Dirmesropian, JG Wood, CR MacIntyre, AT Newall, A review of economic evaluations of 13-valent pneumococcal conjugate vaccine (PCV13) in adults and the elderly Human Vaccines & Immunotherapeutics. ,vol. 11, pp. 818- 825 ,(2015) , 10.1080/21645515.2015.1011954
Sun-Young Kim, Sue J Goldie, Cost-effectiveness analyses of vaccination programmes : a focused review of modelling approaches. PharmacoEconomics. ,vol. 26, pp. 191- 215 ,(2008) , 10.2165/00019053-200826030-00004
Shu-ling Hoshi, Masahide Kondo, Ichiro Okubo, Economic Evaluation of Immunisation Programme of 23-Valent Pneumococcal Polysaccharide Vaccine and the Inclusion of 13-Valent Pneumococcal Conjugate Vaccine in the List for Single-Dose Subsidy to the Elderly in Japan PLOS ONE. ,vol. 10, pp. e0139140- ,(2015) , 10.1371/JOURNAL.PONE.0139140
Marie-Josée J. Mangen, Mark H. Rozenbaum, Susanne M. Huijts, Cornelis H. van Werkhoven, Douwe F. Postma, Mark Atwood, Anna M.M. van Deursen, Arie van der Ende, Diederick E. Grobbee, Elisabeth A.M. Sanders, Reiko Sato, Theo J.M. Verheij, Conrad E. Vissink, Marc J.M. Bonten, G. Ardine de Wit, Cost-effectiveness of adult pneumococcal conjugate vaccination in the Netherlands. European Respiratory Journal. ,vol. 46, pp. 1407- 1416 ,(2015) , 10.1183/13993003.00325-2015
Livio Garattini, Anna Padula, Milene Rangel Da Costa, Economic Evidence of Pneumococcal Vaccination in Older Adults: Uncertain Modelling or Competitive Tendering? PharmacoEconomics. ,vol. 34, pp. 221- 224 ,(2016) , 10.1007/S40273-015-0341-4
Giorgio Liguori, Giorgio Liguori, Antonino Parlato, Antonino Parlato, Alessandro Sanduzzi Zamparelli, Alessandro Sanduzzi Zamparelli, Patrizia Belfiore, Patrizia Belfiore, Francesca Gallé, Francesca Gallé, Valeria Di Onofrio, Valeria Di Onofrio, Carla Riganti, Carla Riganti, Bruno Zamparelli, Bruno Zamparelli, Società Italiana di Health Horizon Scanning (SIHHS), Società Italiana di Health Horizon Scanning (SIHHS), Adult immunization with 13-valent pneumococcal vaccine in Campania region, South Italy: an economic evaluation. Human Vaccines & Immunotherapeutics. ,vol. 10, pp. 492- 497 ,(2014) , 10.4161/HV.26888
Yiling Jiang, Aline Gauthier, Lieven Annemans, Mark van der Linden, Laurence Nicolas-Spony, Xavier Bresse, Cost–effectiveness of vaccinating adults with the 23-valent pneumococcal polysaccharide vaccine (PPV23) in Germany Expert Review of Pharmacoeconomics & Outcomes Research. ,vol. 12, pp. 645- 660 ,(2012) , 10.1586/ERP.12.54
Carlos Castañeda-Orjuela, Nelson Alvis-Guzmán, Ángel José Paternina, Fernando De la Hoz-Restrepo, Cost-effectiveness of the introduction of the pneumococcal polysaccharide vaccine in elderly Colombian population. Vaccine. ,vol. 29, pp. 7644- 7650 ,(2011) , 10.1016/J.VACCINE.2011.08.006